Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
British Journal of Anaesthesia, 2021Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study
Leisman D., Mehta A., Li Y. et al.
Olink Target 96
Alimentary Pharmacology & Therapeutics, 2021Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus‐ and hepatitis C virus‐infected individuals
Koshiol J., Argirion I., Liu Z. et al.
European Journal of Cancer Prevention, 2021Circulating immune- and inflammation-related biomarkers and early-stage noncardia gastric cancer risk
Song M., Rabkin C., Ito H. et al.
British Journal of Dermatology, 2021Large‐scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa*
Navrazhina K., Renert‐Yuval Y., Frew J. et al.
Olink Explore 3072/384
Cell, 2021Gut-microbiota-targeted diets modulate human immune status
Wastyk H., Fragiadakis G., Perelman D. et al.
Nature, 2021Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Arunachalam P., Scott M., Hagan T. et al.
Neoplasia, 2021Plasma proteome alterations by MAPK inhibitors in BRAF-mutated metastatic cutaneous melanoma
Babačić H., Eriksson H., Pernemalm M.
Journal of Neurotrauma, 2021Prognostic Value of a Combination of Circulating Biomarkers in Critically Ill Patients with Traumatic Brain Injury: Results from the European CREACTIVE Study
Gradisek P., Carrara G., Antiga L. et al.
PLOS ONE, 2021Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
Kerzeli I., Lord M., Doroszko M. et al.
Olink Target 96 Mouse
European Journal of Heart Failure, 2021Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction
Kresoja K., Rommel K., Wachter R. et al.
European Journal of Immunology, 2021Differential effects of estradiol and progesterone on human T cell activation in vitro
Papapavlou G., Hellberg S., Raffetseder J. et al.
Translational Psychiatry, 2021Toll-like receptor 4 methylation grade is linked to depressive symptom severity
Rasmusson A., Gallwitz M., Soltanabadi B. et al.
Journal of Extracellular Vesicles, 2021Extracellular vesicle‐mediated endothelial apoptosis and EV‐associated proteins correlate with COVID‐19 disease severity
Krishnamachary B., Cook C., Kumar A. et al.
Scientific Reports, 2021Statistical and machine learning methods for analysis of multiplex protein data from a novel proximity extension assay in patients with ST-elevation myocardial infarction
Maag E., Kulasingam A., Grove E. et al.
Nano Select, 2021Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia
Niemeyer B., Miller C., Ledesma‐Feliciano C. et al.
The American Journal of Clinical Nutrition, 2021Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic
Cauwenberghs N., Prunicki M., Sabovčik F. et al.
EP Europace, 2021Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies
De With R., Artola Arita V., Nguyen B. et al.
eClinicalMedicine, 2021Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial
Laursen J., Søndergaard-Heinrich N., de Melo J. et al.
F1000Research, 2021Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
Ren A., Prassas I., Sugumar V. et al.
Journal of Personalized Medicine, 2021Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
Guldvik I., Ekseth L., Kishan A. et al.
3195 publications
Items per page
2521-2540 of 3195 publications